Intel falls 8.8% after weaker-than-expected guidance and signs of PC weakness

What happened

Intel (INTC) fell 8.8% on November 2, 2026, after management issued weaker-than-expected guidance and cited accelerating PC-market weakness and supply constraints. The move followed the company’s October 29 report that showed revenue strength in its DCAI/server business but offered Q4 revenue guidance of $15–$16 billion and much lower adjusted EPS guidance, according to CNBC and Seeking Alpha. Trading volume that day was 1.9 times its 20-day average as investors reacted to the outlook and reports of production disruptions.

How big was the move

The stock closed at $59.97, down 8.8% for the session and fell 33.7% over the last five sessions. That five-session decline far outpaced the S&P 500, which fell 0.5% on the day and fell 1.8% over five sessions, and the Technology sector median, which fell 1.5% on the day. The stock’s one-day performance was 7.4 percentage points worse than the sector median and amounted to 1.5 times a typical daily move for this stock. With a beta of 2.12, the stock tends to move more than the market, amplifying the impact of company-specific news.

The technical picture

The stock showed marked weakness across key moving averages: it was 35.9% below its 20-day moving average and 40.3% below its 50-day moving average. It was also 31.0% below its 200-day moving average and stood 57.9% below its 52-week high. Shorter-term momentum signaled oversold conditions, with a Relative Strength Index (14 days) of 23, below 30. Volatility was elevated, at 93% annualized over 60 days, higher than 98% of its own readings over five years. Price change metrics showed the stock fell 49.7% over one month and 40.5% over three months, yet it rose 49.3% over one year, 38.8 percentage points ahead of the S&P 500.

Fundamentals and valuation

For the four quarters through September 26, 2026, Intel reported revenue of $59.89 billion, up 12.1% from a year earlier and accelerating from growth of 7.5% one quarter earlier. Diluted earnings per share for that period were $-2.41, a decline of 22414.8% from a year earlier, while gross margin improved to 40.2% from 35.6% a year earlier. Operating margin narrowed to 3.2% from 4.5% a year earlier, free-cash-flow margin stood at 6.3%, and return on invested capital was 1.0%.

The balance sheet showed net debt of 8.4 times EBITDA and the share count over one year increased by 17.1%. On valuation metrics provided, the stock traded at 38.7 times expected earnings on a price to forward earnings basis, with a free-cash-flow yield of 1.1%. PromtFinance scores rank the company weak on Value, Growth and Quality, with scores of 24, 19 and 27 respectively, while Revisions scored 76 and Stability scored 9, reflecting mixed signals about near-term prospects and underlying fundamentals.

Earnings and analyst expectations

Intel’s most recent report on October 29, 2026, showed earnings per share of $0.52 against $0.41 expected, 27.9% above estimates, marking five consecutive quarters beating estimates. The company’s average surprise over the last four reports was 100.0% above estimates, and the typical two-day reaction after recent reports was that the stock rose 0.2%. Management highlighted strong revenue in its DCAI/server business and cited tight supply in that segment.

Despite those beats, management’s Q4 guidance—revenue of $15–$16 billion and much lower adjusted EPS guidance—shocked investors and prompted analyst downgrades. There are 87 analysts covering the stock, with a consensus rating of Hold and a consensus price target of $113.07, 88.5% above the closing price; 37% of analysts rate the stock Buy or Strong Buy. The disparity between analyst targets and current market pricing, together with stretched forward multiples, underlies much of the debate among investors and sell-side research.

What to watch

• January 28, 2027: next scheduled earnings report date.
• October 29, 2026: last report showed earnings per share of $0.52 against $0.41 expected, 27.9% above estimates.
• Management guidance for Q4: revenue of $15–$16 billion and much lower adjusted EPS guidance, cited as the near-term catalyst.
• News on production and supply issues, including reported plant shutdown in Israel and potential supply constraints into mid-2027.
• Analyst actions and revisions following the October guidance, with several downgrades and some contrarian coverage noting stretched valuation and oversold technical conditions.